Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3

A recent clinical trial in African children demonstrated the potential utility of merozoite surface protein (MSP)-3 as a vaccine against Plasmodium falciparum malaria. The present study evaluated the use of Plasmodium vivax MSP-3 (PvMSP-3) as a target antigen in vaccine formulations against malaria...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitencourt, Amanda R., Vicentin, Elaine C., Jimenez, Maria C., Ricci, Ricardo, Leite, Juliana A., Costa, Fabio T., Ferreira, Luis C., Russell, Bruce, Nosten, François, Rénia, Laurent, Galinski, Mary R., Barnwell, John W., Rodrigues, Mauricio M., Soares, Irene S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573074/
https://www.ncbi.nlm.nih.gov/pubmed/23457498
http://dx.doi.org/10.1371/journal.pone.0056061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573074/
https://www.ncbi.nlm.nih.gov/pubmed/23457498
http://dx.doi.org/10.1371/journal.pone.0056061

Ejemplares similares